Wells Fargo & Company Ardelyx, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Ardelyx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 323,642 shares of ARDX stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323,642
Previous 884,165 63.4%
Holding current value
$1.55 Million
Previous $6.55 Million 65.97%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$5.28 - $7.57 $2.96 Million - $4.24 Million
-560,523 Reduced 63.4%
323,642 $2.23 Million
Q2 2024

Aug 13, 2024
BUY
$5.89 - $9.31 $4.52 Million - $7.15 Million
767,586 Added 658.43%
884,165 $6.55 Million
Q1 2024

May 10, 2024
BUY
$6.05 - $9.74 $62,375 - $100,419
10,310 Added 9.7%
116,579 $851,000
Q4 2023

Feb 09, 2024
SELL
$3.29 - $6.64 $589,127 - $1.19 Million
-179,066 Reduced 62.76%
106,269 $658,000
Q3 2023

Nov 13, 2023
SELL
$3.3 - $4.83 $597,890 - $875,094
-181,179 Reduced 38.84%
285,335 $1.16 Million
Q2 2023

Aug 15, 2023
BUY
$3.23 - $4.95 $581,664 - $891,405
180,082 Added 62.87%
466,514 $1.58 Million
Q1 2023

May 12, 2023
BUY
$2.68 - $4.79 $690,649 - $1.23 Million
257,705 Added 897.08%
286,432 $1.37 Million
Q4 2022

Feb 13, 2023
SELL
$1.22 - $2.85 $7,625 - $17,812
-6,250 Reduced 17.87%
28,727 $81,000
Q3 2022

Nov 14, 2022
SELL
$0.59 - $1.44 $1,969 - $4,806
-3,338 Reduced 8.71%
34,977 $41,000
Q2 2022

Aug 12, 2022
SELL
$0.51 - $1.17 $10,481 - $24,045
-20,552 Reduced 34.91%
38,315 $23,000
Q1 2022

May 16, 2022
SELL
$0.65 - $1.18 $22,570 - $40,974
-34,724 Reduced 37.1%
58,867 $63,000
Q4 2021

Feb 14, 2022
SELL
$0.86 - $1.7 $16,028 - $31,684
-18,638 Reduced 16.61%
93,591 $103,000
Q3 2021

Nov 15, 2021
BUY
$1.27 - $8.17 $138,071 - $888,226
108,718 Added 3096.5%
112,229 $148,000
Q2 2021

Aug 16, 2021
SELL
$6.55 - $8.98 $35,723 - $48,976
-5,454 Reduced 60.84%
3,511 $26,000
Q1 2021

May 13, 2021
SELL
$6.1 - $7.69 $466,570 - $588,185
-76,487 Reduced 89.51%
8,965 $59,000
Q4 2020

Feb 09, 2021
SELL
$5.05 - $7.1 $358,938 - $504,646
-71,077 Reduced 45.41%
85,452 $553,000
Q3 2020

Nov 05, 2020
BUY
$5.25 - $7.08 $9,597 - $12,942
1,828 Added 1.18%
156,529 $822,000
Q2 2020

Aug 13, 2020
BUY
$5.37 - $8.11 $605,102 - $913,851
112,682 Added 268.17%
154,701 $1.07 Million
Q1 2020

May 14, 2020
BUY
$4.35 - $8.79 $182,782 - $369,347
42,019 New
42,019 $239,000

Others Institutions Holding ARDX

# of Institutions
218
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email